Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma

This study has been completed.
Information provided by (Responsible Party):
Millennium Pharmaceuticals, Inc. Identifier:
First received: August 20, 2009
Last updated: May 23, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
No publications provided by Millennium Pharmaceuticals, Inc.

Publications automatically indexed to this study by Identifier (NCT Number):